The bionic pancreas, a system that mimics the natural pancreatic regulation of serum glucose by automatically dosing insulin and glucagon, has been a dream for decades. New research to be presented in a mini-symposium at 12:45 p.m. CT on Friday could reveal whether that dream is one step closer to reality, according to Roy W. Beck, MD, PhD.
Coming up: Results from insulin-only bionic pancreas trial to be reported
